secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeward Ltd. (LFWD)
CIK:        0001607962
Form:       8-K
Filed at:   2023-05-11T23:59:59+00:00
Accession:  0001178913-23-001822
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ReWalk Robotics Q1 revenue up 40% to $1.2M; gross margin improves to 46.4%
--------------------------------------------------------------------------

- Total revenue $1.2M vs $0.9M in Q1 2022, a 40% increase driven by higher US unit sales.
- Gross margin 46.4% vs 30.3% in Q1 2022, up 16 percentage points on higher volumes and ASP.
- Net loss $4.3M vs $4.4M; non-GAAP net loss $4.0M vs $4.1M; cash $61.9M with no debt.
- FDA 510(k) clearance for ReWalk Personal Exoskeleton on stairs and curbs in March 2023.
- First Medicare claim submitted; ten additional submissions planned in Q2 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1607962/000117891323001822/0001178913-23-001822-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1607962/000117891323001822/zk2329703.htm
  HTML page:      https://secwatch.observer/filing/0001178913-23-001822

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer